Sign in

Hans Carolus

@hanscarolus.bsky.social
52 followers 56 following 4 posts

Molecular microbiologist fascinated by evolution and neglected pathogens. Postdoc at KU Leuven. Distiller of jenever. I unconditionally love yeast, one gave me a job, another gave me a hobby.

PostsRepliesMedia
Reposted by Hans Carolus
François Mayer @francoismayer.bsky.social · 21/03/2025
Out now in Nature: A polyene macrolide targeting phospholipids in the fungal cell membrane www.nature.com/articles/s41...
nature.com
A polyene macrolide targeting phospholipids in the fungal cell membrane - Nature
Mandimycin, a polyene macrolide, exhibits strong antifungal activity and possesses a mode of action that is distinct from other compounds of this class.
0104
Reposted by Hans Carolus
Clement Tsui PhD 🇭🇰 🇨🇦 @clementsui.bsky.social · 22/03/2025
Rapid spread of #Candida auris in China after COVID-19 - Journal of Infection www.journalofinfection.com/article/S016...
journalofinfection.com
Rapid spread of Candida auris in China after COVID-19
Dear Editor
041
Hans Carolus @hanscarolus.bsky.social · 06/02/2025
Incredible how fungi can evolve! In our latest manuscript, we describe an intriguing case of hyper-MDR in C. glabrata and highlight the therapeutic potential of collateral sensitivity and nitroxoline for such therapeutic dead ends! www.biorxiv.org/content/10.1...
biorxiv.org
Survival of the unfittest: clinical emergence of hyper-multidrug-resistant Nakaseomyces glabratus with rare nonfunctional Erg3 and Erg11 and severely impaired fitness.
Background : Nakaseomyces glabratus (Candida gabrata) poses a significant clinical challenge due to common drug resistance. We report a case of a complicated urinary tract infection (UTI) progressing ...
010
Reposted by Hans Carolus
Oded Rechavi @odedrechavi.bsky.social · 16/01/2025
Logging into microsoft teams
3896
Reposted by Hans Carolus
Nicholas Gervais @nickgervais.bsky.social · 10/01/2025
Extremely validating. I’ll never complain about C. albicans again after working with CRISPR in C. auris
021
Hans Carolus @hanscarolus.bsky.social · 10/01/2025
When I started my PhD 6 years ago, this sticker on my office door got me excited. Sure! let's "CRISPR Candida auris"! Today I am excited to show that that's not as easy as it sounds! 😉 Read our latest preprint on the challenges with editing C. auris: www.biorxiv.org/content/10.1...
142
Hans Carolus @hanscarolus.bsky.social · 17/12/2024
Thrilled to announce I was awarded an EMBO postdoctoral fellowship to join the lab of @christianlandry.bsky.social @ @universitelaval.bsky.social next April! Exciting science across the pond ahead! #EMBOFellows
140
Reposted by Hans Carolus
Ákos T Kovács @evolvedbiofilm.bsky.social · 15/12/2024
Unlocking the potential of experimental evolution to study drug resistance in pathogenic fungi -in NPJ antimicrobials and resistance from @hanscarolus.bsky.social with Patrick van Dijck lab www.nature.com/articles/s44...
nature.com
Unlocking the potential of experimental evolution to study drug resistance in pathogenic fungi - npj Antimicrobials and Resistance
npj Antimicrobials and Resistance - Unlocking the potential of experimental evolution to study drug resistance in pathogenic fungi
0289
Hans Carolus @hanscarolus.bsky.social · 12/12/2024
My first paper as senior author is out! Lots of new ideas for experimental evolution studies with fungi, and again, a nice collaboration with Giorgio Boccarella and Piet van den Berg. www.nature.com/articles/s44...
nature.com
Unlocking the potential of experimental evolution to study drug resistance in pathogenic fungi - npj Antimicrobials and Resistance
npj Antimicrobials and Resistance - Unlocking the potential of experimental evolution to study drug resistance in pathogenic fungi
010
Reposted by Hans Carolus
Comparative genomics group IRB-BSC Barcelona (PI: Toni Gabaldón) @gabaldonlab.bsky.social · 04/12/2024
#paper #candida #AMR Acquired amphotericin B resistance leads to fitness trade-offs that can be mitigated by compensatory evolution in Candida auris @naturemicrobiol.bsky.social @tonigabaldon.bsky.social nice collab with @hanscarolus.bsky.social www.nature.com/articles/s41...
042
Reposted by Hans Carolus
François Mayer @francoismayer.bsky.social · 04/12/2024
In case you missed these two recent Nature Microbiology studies on Candida auris AMR by @hanscarolus.bsky.social and colleagues: www.nature.com/articles/s41...
nature.com
Collateral sensitivity counteracts the evolution of antifungal drug resistance in Candida auris - Nature Microbiology
Collateral-sensitivity-based drug cycling effectively prevents and impedes the evolution of antifungal drug resistance in Candida auris.
151